CIRCULATORY FAILURE (SHOCK) • Circulatory shock can be described as an acute failure of the circulatory system to supply the peripheral tissues and organs of the body with an adequate blood supply, resulting in cellular hypoxia. • Most often hypotension and hypoperfusion are present, but shock may occur in the presence of normal vital signs. CIRCULATORY FAILURE (SHOCK) • Shock is not a specific disease but a syndrome that can occur in the course of many life-threatening traumatic conditions or disease states. • It can be caused by an alteration in cardiac function (cardiogenic shock), a decrease in blood volume (hypovolemic shock), excessive vasodilation with maldistribution of blood flow (distributive shock), or obstruction of blood flow through the circulatory system (obstructive shock). CIRCULATORY FAILURE (SHOCK) Pathophysiology of Circulatory Shock • Circulatory failure results in hypoperfusion of organs and tissues, which in turn results in insufficient supply of oxygen and nutrients for cellular function. • There are compensatory physiologic responses that eventually decompensate into various shock states if the condition is not properly treated in a timely manner. – The most immediate of the compensatory mechanisms are the sympathetic and renin systems, which are designed to maintain cardiac output and blood pressure. CIRCULATORY FAILURE (SHOCK) Pathophysiology of Circulatory Shock • There are two types of adrenergic receptors for the sympathetic nervous system: α and β. – The β receptors are further subdivided into β1 and β2 receptors. – Stimulation of the α receptors causes vasoconstriction; stimulation of β1 receptors, an increase in heart rate and force of myocardial contraction; and of β2 receptors, vasodilation of the skeletal muscle beds and relaxation of the bronchioles. • In shock, there is an increase in sympathetic outflow that results in increased epinephrine and norepinephrine release, and activation of both α and β receptors. CIRCULATORY FAILURE (SHOCK) Pathophysiology of Circulatory Shock • Thus, increases in heart rate and vasoconstriction occur in most types of shock. • There also is an increase in renin release, leading to an increase in angiotensin II, which augments vasoconstriction and leads to an aldosterone-mediated increase in sodium and water retention by the kidneys. – In addition, there is local release of vasoconstrictors, including norepinephrine, angiotensin II, vasopressin, and endothelin, which contribute to arterial and venous vasoconstriction. CIRCULATORY FAILURE (SHOCK) Pathophysiology of Circulatory Shock • The compensatory mechanisms that the body recruits are not effective over the long term and become detrimental when the shock state is prolonged. • The intense vasoconstriction causes a decrease in tissue perfusion and insufficient supply of oxygen. CIRCULATORY FAILURE (SHOCK) Pathophysiology of Circulatory Shock • Cellular metabolism is impaired, vasoactive inflammatory mediators such as histamine are released, production of oxygen free radicals is increased, and excessive lactic acid and hydrogen ions result in intracellular acidity. • Each of these factors promotes cellular dysfunction or death. If circulatory function is reestablished, whether the shock is irreversible or the patient will survive is determined largely at the cellular level. CIRCULATORY FAILURE (SHOCK) Pathophysiology of Circulatory Shock • Shock ultimately exerts its effect at the cellular level, with failure of the circulation to supply the cell with the oxygen and nutrients needed for production of ATP. The cell uses ATP for a number of purposes, including operation of the sodium potassium membrane pump that moves sodium out of the cell and potassium back into the cell. CIRCULATORY FAILURE (SHOCK) Pathophysiology of Circulatory Shock • The cell uses two pathways to convert nutrients to energy. – The first is the anaerobic (non–oxygen-dependent) glycolytic pathway, which is located in the cytoplasm. Glycolysis converts glucose to ATP and pyruvate. – The second pathway is the aerobic (oxygen-dependent) pathway, called the citric acid cycle, which is located in the mitochondria. When oxygen is available, pyruvate from the glycolytic pathway moves into the mitochondria and enters the citric acid cycle, where it is transformed into ATP and the metabolic byproducts carbon dioxide and water. CIRCULATORY FAILURE (SHOCK) Pathophysiology of Circulatory Shock • When oxygen is lacking, pyruvate does not enter the citric acid cycle; instead, it is converted to lactic acid. The anaerobic pathway, although allowing energy production to continue in the absence of oxygen, is relatively inefficient and produces significantly less ATP than the aerobic pathway. CIRCULATORY FAILURE (SHOCK) Pathophysiology of Circulatory Shock • In severe shock, cellular metabolic processes are essentially anaerobic owing to the decreased availability of oxygen. • Excess amounts of lactic acid accumulate in the cellular and the extracellular compartments, and limited amounts of ATP are produced. Without sufficient energy production, normal cell function cannot be maintained. The sodium potassium membrane pump is impaired, resulting in excess sodium inside the cells and potassium loss from cells. CIRCULATORY FAILURE (SHOCK) CIRCULATORY FAILURE (SHOCK) Pathophysiology of Circulatory Shock • The increase in intracellular sodium results in cellular edema and increased cell membrane permeability. Mitochondrial activity becomes severely depressed and lysosomal membranes may rupture, resulting in the release of enzymes that cause further intracellular destruction. • This is followed by cell death and the release of intracellular contents into the extracellular space. The destruction of the cell membrane activates the arachidonic acid cascade, release of inflammatory mediators, and production of oxygen free radicals that extend cellular damage. CIRCULATORY FAILURE (SHOCK) Pathophysiology of Circulatory Shock • The extent of the microvascular injury and organ dysfunction is primarily determined by the extent of the shock state and whether it is prolonged. • Interventions are targeted at both prevention and early intervention, when possible. CIRCULATORY FAILURE (SHOCK) Cardiogenic Shock • Cardiogenic shock occurs when the heart fails to pump blood sufficiently to meet the body’s demands. Clinically, it is defined as decreased cardiac output, hypotension, hypoperfusion, and indications of tissue hypoxia, despite adequate intravascular volume. • Cardiogenic shock may occur suddenly from a number of causes, including myocardial infarction, myocardial contusion, sustained arrhythmias, and cardiac surgery. Cardiogenic shock also may ensue as an end-stage condition of coronary artery disease or cardiomyopathy. CIRCULATORY FAILURE (SHOCK) Cardiogenic Shock Pathophysiology • The most common cause of cardiogenic shock is myocardial infarction. Most patients who die of cardiogenic shock have had extensive damage to the contracting muscle of the left ventricle because of a recent infarct or a combination of recent and old infarctions. • Cardiogenic shock can occur with other types of shock because of inadequate coronary blood flow, or it can develop because substances released from ischemic tissues impair cardiac function. CIRCULATORY FAILURE (SHOCK) Cardiogenic Shock Pathophysiology • One unidentified substance, called myocardial depressant factor, is thought to be released into the circulation during septic shock. There are conflicting data on the identity of myocardial depressant factor; however, inflammatory mediators such as TNF have been suggested as possible agents. • It has been hypothesized that the myocardial depressant factor produces severe but potentially reversible myocardial depression, ventricular dilation, and decreased left ventricular ejection fraction and diastolic pressure. CIRCULATORY FAILURE (SHOCK) Cardiogenic Shock Pathophysiology • Regardless of cause, persons with cardiogenic shock have a decrease in stroke volume and cardiac output, which results in insufficient perfusion to meet cellular demands for oxygen. • The poor cardiac output is due to decreased myocardial contractility, increased afterload, and excessive preload. Mediators and neurotransmitters, including norepinephrine, produce an increase in systemic vascular resistance, which increases afterload and contributes to the deterioration of cardiac function. CIRCULATORY FAILURE (SHOCK) Cardiogenic Shock Pathophysiology • Preload, or the filling pressure of the heart, is increased as blood returning to the heart is added to blood that previously was not pumped forward, resulting in an increase in left ventricular end- systolic volume. Activation of the renin-angiotensin aldosterone mechanism worsens both preload and afterload by producing an aldosterone-mediated increase in fluid retention and an angiotensin-II–mediated increase in vasoconstriction. CIRCULATORY FAILURE (SHOCK) Cardiogenic Shock Pathophysiology • The increased resistance (i.e., afterload) to ejection of blood from the left ventricle, in combination with a decrease in myocardial contractility, results in an increase in end-systolic ventricular volume and preload, which further impairs the heart’s ability to pump effectively. CIRCULATORY FAILURE (SHOCK) Cardiogenic Shock Pathophysiology • Eventually, coronary artery perfusion is impaired because of the increased preload and afterload, and cardiac function decreases because of poor myocardial oxygen supply. There is an increase in intracardiac pressures due to volume overload and ventricular wall tension in both diastole and systole. CIRCULATORY FAILURE (SHOCK) Cardiogenic Shock Pathophysiology • Excessive pressures decrease coronary artery perfusion during diastole, and increased wall tension decreases coronary artery perfusion during systole. If treatment is unsuccessful, cardiogenic shock may result in a systemic inflammatory response syndrome, evidenced by increased white blood cell count, increased temperature, and release of inflammatory markers such as CRP. CIRCULATORY FAILURE (SHOCK) Cardiogenic Shock CIRCULATORY FAILURE (SHOCK) Hypovolemic Shock • Hypovolemic shock is characterized by diminished blood volume such that there is inadequate filling of the vascular compartment. • It occurs when there is an acute loss of 15% to 20% of the circulating blood volume. CIRCULATORY FAILURE (SHOCK) Hypovolemic Shock • The decrease may be caused by an external loss of whole blood (e.g., hemorrhage), plasma (e.g., severe burns), or extracellular fluid (e.g., severe dehydration or loss of gastrointestinal fluids with vomiting or diarrhea). • Hypovolemic shock also can result from an internal hemorrhage or from third-space losses, when extracellular fluid is shifted from the vascular compartment to the interstitial space or compartment. CIRCULATORY FAILURE (SHOCK) Hypovolemic Shock Pathophysiology • Hypovolemic shock, which has been the most widely studied type of shock, is often used as a prototype in discussions of the manifestations of shock. Figure shows the effect of removing blood from the circulatory system during approximately 30 minutes. CIRCULATORY FAILURE (SHOCK) CIRCULATORY FAILURE (SHOCK) Hypovolemic Shock CIRCULATORY FAILURE (SHOCK) Hypovolemic Shock Pathophysiology • Approximately 10% of the total blood volume can be removed without changing cardiac output or arterial pressure. The average blood donor loses approximately 500 mL or 10% of their blood without experiencing adverse effects. CIRCULATORY FAILURE (SHOCK) Hypovolemic Shock Pathophysiology • As increasing amounts of blood (10% to 25%) are removed, the stroke volume falls but arterial pressure is maintained because of sympathetic-mediated increases in heart rate and vasoconstriction. Vasoconstriction results in an increased diastolic pressure and narrow pulse pressure. • Blood pressure is the product of cardiac output and systemic vascular resistance (blood pressure = cardiac output × systemic vascular resistance). CIRCULATORY FAILURE (SHOCK) Hypovolemic Shock Pathophysiology • An increase in systemic vascular resistance maintains mean arterial pressure for a short time despite decreased cardiac output. • Cardiac output and tissue perfusion decrease before signs of hypotension appear. Cardiac output and arterial pressure fall to zero when approximately 35% to 45% of the total blood volume has been removed. CIRCULATORY FAILURE (SHOCK) Hypovolemic Shock Compensatory Mechanisms. • Without compensatory mechanisms to maintain cardiac output and blood pressure, the loss of vascular volume would result in a rapid progression from the initial to the progressive and irreversible stages of shock. • The most immediate of the compensatory mechanisms are the sympathetic-mediated responses designed to maintain cardiac output and blood pressure . CIRCULATORY FAILURE (SHOCK) Hypovolemic Shock CIRCULATORY FAILURE (SHOCK) Hypovolemic Shock Compensatory Mechanisms. • Within seconds after the onset of hemorrhage or the loss of blood volume, tachycardia, increased cardiac contractility, vasoconstriction, and other signs of sympathetic and adrenal medullary activity appear. • The sympathetic vasoconstrictor response also mobilizes blood that has been stored in the venous side of the circulation as a means of increasing venous return to the heart. CIRCULATORY FAILURE (SHOCK) Hypovolemic Shock Compensatory Mechanisms. • There is considerable capacity for blood storage in the large veins of the abdomen, and approximately 350 mL of blood that can be mobilized in shock is stored in the liver. • Sympathetic stimulation does not initially cause constriction of the cerebral and coronary vessels, and blood flow to the heart and brain is maintained at essentially normal levels as long as the mean arterial pressure remains above 70 mm Hg. CIRCULATORY FAILURE (SHOCK) Hypovolemic Shock Compensatory Mechanisms. • Compensatory mechanisms designed to restore blood volume include absorption of fluid from the interstitial spaces, conservation of sodium and water by the kidneys, and thirst. • Extracellular fluid is distributed between the interstitial spaces and the vascular compartment. When there is a loss of vascular volume, capillary pressures decrease and water is drawn into the vascular compartment from the interstitial spaces. The maintenance of vascular volume is further enhanced by renal mechanisms that conserve fluid. CIRCULATORY FAILURE (SHOCK) Hypovolemic Shock Compensatory Mechanisms. • A decrease in renal blood flow and glomerular filtration rate results in activation of the renin angiotensin-aldosterone mechanism, which produces an increase in sodium reabsorption by the kidneys. CIRCULATORY FAILURE (SHOCK) Hypovolemic Shock Compensatory Mechanisms. • The decrease in blood volume also stimulates centers in the hypothalamus that regulate ADH release and thirst. ADH, also known as vasopressin, constricts the peripheral arteries and veins and greatly increases water retention by the kidneys. • Although the mechanism of ADH is more sensitive to changes in serum osmolality, a decrease of 10% to 15% in blood volume serves as a strong stimulus for thirst. CIRCULATORY FAILURE (SHOCK) Hypovolemic Shock Compensatory Mechanisms. • During the early stages of hypovolemic shock, vasoconstriction decreases the size of the vascular compartment and increases systemic vascular resistance. This response usually is all that is needed when the injury is slight and blood loss is minimal. CIRCULATORY FAILURE (SHOCK) Hypovolemic Shock Compensatory Mechanisms. • As hypovolemic shock progresses, vasoconstriction of the blood vessels that supply the skin, skeletal muscles, kidneys, and abdominal organs becomes more severe, with a further decrease in blood flow and conversion to anaerobic metabolism resulting in cellular injury. CIRCULATORY FAILURE (SHOCK) Distributive Shock • Distributive or vasodilatory shock is characterized by loss of blood vessel tone, enlargement of the vascular compartment, and displacement of the vascular volume away from the heart and central circulation. • In distributive shock, the capacity of the vascular compartment expands to the extent that a normal volume of blood does not fill the circulatory system. Therefore, this type of shock is also referred to as normovolemic shock. CIRCULATORY FAILURE (SHOCK) Distributive Shock • Two main causes result in the loss of vascular tone: – a decrease in the sympathetic control of vasomotor tone or – the release of excessive vasodilator substances. CIRCULATORY FAILURE (SHOCK) Distributive Shock • It can also occur as a complication of vessel damage resulting from prolonged and severe hypotension due to hemorrhage, known as irreversible or late-phase hemorrhagic shock. • There are three shock states that share the basic circulatory pattern of distributive shock: – neurogenic shock, – anaphylactic shock, and – septic shock. CIRCULATORY FAILURE (SHOCK) Distributive Shock Neurogenic Shock • Neurogenic shock is caused by decreased sympathetic control of blood vessel tone due to a defect in the vasomotor center in the brain stem or the sympathetic outflow to the blood vessels. The term spinal shock describes the neurogenic shock that occurs in persons with spinal cord injury. CIRCULATORY FAILURE (SHOCK) Distributive Shock Neurogenic Shock • Output from the vasomotor center can be interrupted by brain injury, the depressant action of drugs, general anesthesia, hypoxia, or lack of glucose (e.g., insulin reaction). CIRCULATORY FAILURE (SHOCK) Distributive Shock Neurogenic Shock • Fainting due to emotional causes is a transient form of impaired sympathetic outflow. Many general anesthetic agents can cause a neurogenic shock–like reaction, especially during induction, because of interference with sympathetic nervous system function. CIRCULATORY FAILURE (SHOCK) Distributive Shock Neurogenic Shock • Spinal anesthesia or spinal cord injury above the mid-thoracic region can interrupt the transmission of outflow from the vasomotor center. CIRCULATORY FAILURE (SHOCK) Distributive Shock Neurogenic Shock • In contrast to other shock states due to the loss of blood volume or impaired cardiac function, the heart rate in neurogenic shock often is slower than normal, and the skin is dry and warm. This type of distributive shock is rare and usually transitory. CIRCULATORY FAILURE (SHOCK) Distributive Shock Anaphylactic Shock • Anaphylaxis is a clinical syndrome that represents the most severe systemic allergic reaction. • Anaphylactic shock results from an immunologically mediated reaction in which vasodilator substances such as histamine are released into the blood. These substances cause vasodilation of arterioles and venules along with a marked increase in capillary permeability. The vascular response in anaphylaxis is often accompanied by life-threatening laryngeal edema and bronchospasm, circulatory collapse, contraction of gastrointestinal and uterine smooth muscle, and urticaria (hives) or angioedema. CIRCULATORY FAILURE (SHOCK) Distributive Shock Anaphylactic Shock • Among the most frequent causes of anaphylactic shock are reactions to medications, such as penicillin; foods, such as nuts and shellfish; and insect venoms. • The most common cause is stings from insects of the order Hymenoptera (i.e., bees, wasps, and fire ants). Latex allergy causes life-threatening anaphylaxis in a growing segment of the population. CIRCULATORY FAILURE (SHOCK) Distributive Shock Anaphylactic Shock • Health care workers and others who are exposed to latex are developing latex sensitivities that range from mild urticaria, contact dermatitis, and mild respiratory distress to anaphylactic shock. • Children with spina bifida also are at extreme risk for this serious and increasingly common allergy. CIRCULATORY FAILURE (SHOCK) Distributive Shock Anaphylactic Shock • The onset and severity of anaphylaxis depend on the sensitivity of the person and the rate and quantity of antigen exposure. • Signs and symptoms associated with impending anaphylactic shock include abdominal cramps; apprehension; warm or burning sensation of the skin, itching, and urticaria (i.e., hives); and coughing, choking, wheezing, chest tightness, and difficulty in breathing. CIRCULATORY FAILURE (SHOCK) Distributive Shock Anaphylactic Shock • After blood begins to pool peripherally, there is a precipitous drop in blood pressure and the pulse becomes so weak that it is difficult to detect. • Life-threatening airway obstruction may ensue as a result of laryngeal angioedema or bronchial spasm. Anaphylactic shock often develops suddenly; death can occur within minutes unless appropriate medical intervention is promptly instituted. CIRCULATORY FAILURE (SHOCK) Distributive Shock Anaphylactic Shock • Treatment includes immediate discontinuation of the inciting agent or institution of measures to decrease its absorption (e.g., application of ice to the site of an insect bite); close monitoring of cardiovascular and respiratory function; and maintenance of respiratory gas exchange, cardiac output, and tissue perfusion. Epinephrine is given in an anaphylactic reaction because it constricts blood vessels and relaxes the smooth muscle in the bronchioles, thus restoring cardiac and respiratory function. CIRCULATORY FAILURE (SHOCK) Distributive Shock Anaphylactic Shock • Other treatment measures include the administration of oxygen, antihistamine drugs, and corticosteroids. The person should be placed in a supine position. This is extremely important because venous return can be severely compromised in the sitting position. This in turn produces a pulseless mechanical contraction of the heart and predisposes to arrhythmias. In several cases, death has occurred immediately after assuming the sitting position. CIRCULATORY FAILURE (SHOCK) Distributive Shock Anaphylactic Shock • The prevention of anaphylactic shock is preferable to treatment. Once a person has been sensitized to an antigen, the risk of repeated anaphylactic reactions with subsequent exposure is high. All health care providers should question patients regarding previous drug reactions and inform patients as to the name of the medication they are to receive before it is administered or prescribed. CIRCULATORY FAILURE (SHOCK) Distributive Shock Anaphylactic Shock • Persons with known hypersensitivities should wear Medic Alert jewelry and carry an identification card to alert medical personnel if they become unconscious or unable to relate this information. Persons who are at risk for anaphylaxis should be provided with emergency medications (e.g., epinephrine autoinjector) and instructed in procedures to follow in case they are inadvertently exposed to the offending antigen. CIRCULATORY FAILURE (SHOCK) Distributive Shock Sepsis and Septic Shock Septic shock, which is the most common type of vasodilatory shock, is associated with severe infection and the systemic response to infection. CIRCULATORY FAILURE (SHOCK) Distributive Shock Sepsis and Septic Shock The nomenclature related to sepsis and septic shock has been evolving. – Sepsis is currently defined as suspected or proven infection, plus a systemic inflammatory response (e.g., fever, tachycardia, tachypnea, and elevated white blood cell count, altered mental state, and hyperglycemia in the absence of diabetes). – Severe sepsis is defined as sepsis with organ dysfunction (e.g., hypotension, hypoxemia, oliguria, metabolic acidosis, thrombocytopenia, or obtundation). – Septic shock is defined as severe sepsis with hypotension, despite fluid resuscitation. CIRCULATORY FAILURE (SHOCK) Distributive Shock Sepsis and Septic Shock CIRCULATORY FAILURE (SHOCK) Distributive Shock Sepsis and Septic Shock • It is estimated that more than 750,000 cases of sepsis occur each year in the United States, leading to approximately 225,000 deaths. The growing incidence has been attributed to enhanced awareness of the diagnosis, increased number of resistant organisms, growing number of immunocompromised and elderly persons, and greater use of invasive procedures. CIRCULATORY FAILURE (SHOCK) Distributive Shock Sepsis and Septic Shock • With early intervention and advances in treatment methods, the mortality rate has decreased; however, the number of deaths has increased because of the increased prevalence. CIRCULATORY FAILURE (SHOCK) Distributive Shock Sepsis and Septic Shock Mechanisms. • The pathogenesis of sepsis involves a complex process of cellular activation resulting in the release of proinflammatory mediators such as cytokines; recruitment of neutrophils and monocytes; involvement of neuroendocrine reflexes; and activation of complement, coagulation, and fibrinolytic systems. • Initiation of the response begins with activation of the innate immune system by pattern-recognition receptors (e.g., Toll-like receptors [TLRs]) that interact with specific molecules present on microorganisms. CIRCULATORY FAILURE (SHOCK) Distributive Shock Sepsis and Septic Shock Mechanisms. • Binding of TLRs to epitopes on microorganisms stimulates transcription and release of a number of proinflammatory and anti- inflammatory mediators. Two of these mediators, TNF-α and interleukin-1, are involved in leukocyte adhesion, local inflammation, neutrophil activation, suppression of erythropoiesis, generation of fever, tachycardia, lactic acidosis, ventilation- perfusion abnormalities, and other signs of sepsis. CIRCULATORY FAILURE (SHOCK) Distributive Shock Sepsis and Septic Shock Mechanisms. • Although activated neutrophils kill microorganisms, they also injure the endothelium by releasing mediators that increase vascular permeability. In addition, activated endothelial cells release nitric oxide, a potent vasodilator that acts as a key mediator of septic shock. CIRCULATORY FAILURE (SHOCK) Distributive Shock Sepsis and Septic Shock Mechanisms. • Another important aspect of sepsis is an alteration of the procoagulation–anticoagulation balance with an increase in procoagulation factors and a decrease in anticoagulation factors. Lipopolysaccharide on the surface of microorganisms stimulates endothelial cells lining blood vessels to increase their production of tissue factor, thus activating coagulation. CIRCULATORY FAILURE (SHOCK) Distributive Shock Sepsis and Septic Shock Mechanisms. • Fibrinogen is then converted to fibrin, leading to the formation of microvascular thrombi that further amplify tissue injury. • In addition, sepsis lowers levels of protein C, protein S, antithrombin III, and tissue factor pathway inhibitor, substances that modulate and inhibit coagulation. CIRCULATORY FAILURE (SHOCK) Distributive Shock Sepsis and Septic Shock Mechanisms. • Lipopolysaccharide and TNF-α also decrease the synthesis of thrombomodulin and endothelial protein C receptor, impairing activation of protein C, and they increase the synthesis of plasminogen activator inhibitor-1, impairing fibrinolysis. CIRCULATORY FAILURE (SHOCK) Obstructive Shock • The term obstructive shock describes circulatory shock that results from mechanical obstruction of the flow of blood through the central circulation. CIRCULATORY FAILURE (SHOCK) Obstructive Shock • Obstructive shock may be caused by a number of conditions, including dissecting aortic aneurysm, cardiac tamponade, pneumothorax, atrial myxoma, and evisceration of abdominal contents into the thoracic cavity because of a ruptured hemidiaphragm. • The most frequent cause of obstructive shock is pulmonary embolism. CIRCULATORY FAILURE (SHOCK) Obstructive Shock • The primary physiologic result of obstructive shock is elevated right heart pressure due to impaired right ventricular function. • Pressures are increased despite impaired venous return to the heart. Signs of right heart failure occur, including elevation of CVP and jugular venous distention. CIRCULATORY FAILURE (SHOCK) Obstructive Shock • Treatment modalities focus on correcting the cause of the disorder, frequently with surgical interventions such as pulmonary embolectomy, pericardiocentesis (i.e., removal of fluid from the pericardial sac) for cardiac tamponade, or the insertion of a chest tube for correction of a tension pneumothorax or hemothorax. • In severe or massive pulmonary embolus, fibrinolytic drugs may be used to break down the clots causing the obstruction. CIRCULATORY FAILURE (SHOCK) Complications of Shock • Carl Wiggers, a noted circulatory physiologist, stated, “Shock not only stops the machine, but it wrecks the machinery.” • Many body systems are wrecked by severe shock. CIRCULATORY FAILURE (SHOCK) Complications of Shock • Five major complications of severe shock are pulmonary injury, acute renal failure, gastrointestinal ulceration, disseminated intravascular coagulation, and multiple organ dysfunction syndrome. • These complications of shock are serious and often fatal. CIRCULATORY FAILURE (SHOCK) Complications of Shock – Acute Lung Injury/Acute Respiratory Distress Syndrome – Acute Renal Failure – Gastrointestinal Complications – Disseminated Intravascular Coagulation – Multiple Organ Dysfunction Syndrome